NC3Rs/Innovate UK workshop: Delivering the Government’s alternative methods strategy – Pharmacokinetic and cardiovascular safety studies
Advances in in vitro and in silico approaches are reshaping drug development by improving the prediction of efficacy, safety and pharmacokinetics. This workshop will focus on two priority targets identified in the UK Government’s 2025 […]




